CASTRATION RESISTANT PROSTATIC CANCER

Clinical trials for CASTRATION RESISTANT PROSTATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new CASTRATION RESISTANT PROSTATIC CANCER trials appear

Sign up with your email to follow new studies for CASTRATION RESISTANT PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 2 Completed 1 Terminated 2

New Two-Drug attack on tough cancers shows early promise

Disease control Completed

This early-stage study tested the safety of combining two experimental drugs, vobramitamab duocarmazine and lorigerlimab, in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and see how the body processes …

Matched conditions: CASTRATION RESISTANT PROSTATIC CANCER

Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

CASTRATION RESISTANT PROSTATIC CANCER

Get alerted when new CASTRATION RESISTANT PROSTATIC CANCER trials appear

New Two-Drug attack on tough cancers shows early promise